Global Evaluation of Cholecystectomy Knowledge and Outcomes, Indonesia

Udayana University92 enrolled

Overview

GECKO is a prospective, international, multicentre, observational cohort study delivered by GlobalSurg Collaborative. This will be on consecutive patients undergoing cholecystectomy, between 31st July 2023 to 19th November 2023, with follow-up at 30-day and one-year postoperatively. Mini-teams of up to five collaborators per 14-day data collection period will prospectively collect data at each participating centre. The primary aim is to define the global variation in compliance to pre-, intra-, and post-operative audit standards. The subjects will be observed and interviewed during pre-surgery hospitalization up to one-year post-surgery.

Audit Standards include: 1. Pre-operative * Interventional radiology service * Risk Stratification (Tokyo Guidelines). * Timing of surgery 2. Intraoperative * Critical Safety View (CVS) * Intraoperative imaging * Bailout Procedures * Antibiotic use * Use of drains * Bile Duct Injury (BDI) 3. Postoperative * 30-day readmission * Critical Care

Study Type

OBSERVATIONAL

Enrollment

Conditions

Cholecystectomy

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All adult patients (greater than or including 18 years of age) * Undergo primary cholecystectomy (as the main procedure) * Any open, laparoscopic, robotic approaches are eligible * Elective, delayed and emergency cholecystectomy Exclusion Criteria: * Cholecystectomy as a part of another surgical procedure (Whipple's, bariatric, transplant) * Patients with Mirizzi syndrome * Patients returning to theatre and requiring a cholecystectomy for whatever indication * Known gallbladder malignancy: Gallbladder cancer diagnosed preoperatively

Outcomes

Primary Outcomes

30-day mortality

All-cause mortality rate at 30-days after cholecystectomy, assessed as dichotomous variable (survivor vs non-survivor)

Time frame: 30 days after the surgery

1-year mortality

All-cause mortality rate at 1-year after cholecystectomy, assessed as dichotomous variable (survivor vs non-survivor)

Time frame: 1 year after the surgery

Secondary Outcomes

Critical care admission

All-cause ICU admission rate at 24-hours after cholecystectomy, assessed as dichotomous variable (yes vs no)

Time frame: 24 hours after the surgery

30-day readmission

All-cause readmission rate at 30-days after cholecystectomy, assessed as dichotomous variable (yes vs no)

Time frame: 30 days after surgery